Hormonal Contraceptives Market

Hormonal Contraceptives Market - Analysis and Global Forecast to 2021

Report Code: UC 1458 Nov, 2022, by marketsandmarkets.com

Hormonal contraception is one of birth control methods which act on the endocrine system. Several types of female hormones are used to prevent ovulation and avoid fertilization. Hormonal contraception also results in changes in the uterus making it unlikely to develop pregnancy. Hormonal contraceptives are available in a variety of forms like patch worn on the skin, pill, injection, implant in the arm, or intrauterine devices. These are safe and reliable forms of hormonal contraceptives to prevent pregnancy.

The global hormonal contraceptives market is likely to show significant growth during the forecast period. This is attributed to the urbanization, increasing user awareness, rise in menstruating population worldwide, and encouragement by government to use contraceptives.

The hormonal contraceptives market is segmented by method, by hormone, by end users and by geography. Based on method, the market is segmented into combined oral, oral, implanted, injected, intrauterine, transdermal patch, and vaginal ring contraceptives. The hormonal contraceptives market, by hormone is categorized into androgens, estrogens, progestrogens, gonadotropins, antiandrogens, and others. Based on end users, the market is segmented into hospitals, homecare, gynecology centers, clinics, and ambulatory surgical centers (ASC).

On the basis of regions, the global hormonal contraceptives market is segmented into North America, Europe, Asia-Pacific and Rest of the World (RoW) which includes Latin America and Middle East & Africa.

Some of the major players in the global hormonal contraceptives market  Amgen (U.S.), Bayer Healthcare Pharmaceuticals (Germany), Cipla Limited (India), Glenmark Pharmaceuticals (India), Lupin Pharmaceuticals, Inc (India), Novartis AG (Switzerland), Pfizer, Inc. (U.S.), Piramal Healthcare Limited (India), Sun Pharmaceutical Industries Ltd. (India), and Teva Pharmaceutical Industries (Israel).

Table of Contents

1 Introduction
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency & Pricing
    1.5 Limitation
    1.6 Stakeholders

2 Research Methodology
    2.1 Research Methodology Steps
    2.2 Secondary and Primary Research Methodology
           2.2.1 Secondary Research
                    2.2.1.1 Key Data From Secondary Sources
           2.2.2 Primary Research
                    2.2.2.1 Key Data From Primary Sources
    2.3 Market Size Estimation Methodology
    2.4 Market Forecast Methodology
    2.5 Market Data Validation and Data Triangulation
    2.6 Assumptions

3 Executive Summary
    3.1 Introduction
    3.2 Conclusion

4 Premium Insights

5 Market Overview
    5.1 Introduction
    5.2 Market Segmentation
    5.3 Market Dynamics
           5.3.1 Drivers
           5.3.2 Restraints
           5.3.3 Opportunities
           5.3.4 Challenges

6 Hormonal Contraceptives Market, By Method
    6.1 Introduction
    6.2 Combined Oral Contraceptives
    6.3 Oral Contraceptives
    6.4 Implanted Contraceptives
    6.5 Injected Contraceptives
    6.6 Intrauterine
    6.7 Trasdermal Patch
    6.8 Vaginal Ring

7 Hormonal Contraceptives Market, By Hormones
    7.1 Introduction
    7.2 Androgens
    7.3 Estrogens
    7.4 Progestogens
    7.5 Gonadotropins
    7.6 Antiandrogens
    7.7 Others

8 Hormonal Contraceptivesmarket, By End-Users
    8.1 Introduction
    8.2 Hospitals
    8.3 Homecare
    8.4 Gynecology Centers
    8.5 Clinics
    8.6 Ambulatory Surgical Centers (ASC)

9 Hormonal Contraceptives Market, By Geography
    9.1 Introduction
    9.2 North America
           9.2.1 U.S.
           9.2.2 Canada
    9.3 Europe
    9.4 Asia-Pacific
    9.5 Rest of the World


10 Competitive Landscape
     10.1 Overview
     10.2 Market Share Analysis
     10.3 Competitive Situation and Trends
             10.3.1 New Product Launches
             10.3.2 Expansions
             10.3.3 Agreements, Partnerships, and Collborations
             10.3.4 Acquisitions
             10.3.5 Others

11 Company Profiles
(Overview, Financials, Products & Services, Strategy, & Developments)*
     11.1 Introduction
     11.2 Amgen
     11.3 Bayer Healthcare Pharmaceuticals
     11.4 Cipla Limited
     11.5 Glenmark Pharmaceuticals
     11.6 Lupin Pharmaceuticals, Inc.
     11.7 Novartis AG
     11.8 Pfizer, Inc.
     11.9 Piramal Healthcare Limited
     11.10 Sun Pharmaceutical Industries Ltd.
     11.11 Teva Pharmaceutical Industries

12 Appendix
     12.1 Discussion Guide
     12.2 Introducing Rt: Real-Time Market Intelligence
     12.3 Available Customizations
     12.4 Related Reports

Note:
1. All the Above Markets Will Be Provided for the Years 2014, 2015, 2016, and 2021
2. Revenue for Companies Listed Under “Company Profile” Section (Chapter 10) Might Not Be Captured for Companies Whose Financial Data is Not Available in Public Domain
3. The Above Scope is Tentative and is Subject to Change as the Research Progresses


Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
2 4 9 0 9  
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Hormonal Contraceptives Market Size,  Share & Growth Report
Report Code
UC 1458
Available for Pre-Book
Choose License Type
Prebook Now
GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

SEND ME A FREE SAMPLE
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2022 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status